Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Fridriksdottir Hafrun, Vice-Président Exécutif. Insider active across 1 company, notably Teva Pharmaceutical Industries Ltd. In total, 6 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €1.4m. History available since 10 August 2021. The latest transaction was disclosed on 17 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Hafrun Fridriksdottir is Executive Vice President, Global R&D at Teva Pharmaceutical Industries Ltd. She plays a key role in innovation and the development of new products, contributing to the company's mission to provide health solutions.